• GSK1904529A
  • 2286-25
  • 25 mg
A potent, selective, reversible and ATP-competitive inhibitor of the insulin-like growth factor-1 receptor (IGF-1R) and Insulin Receptor (IR) with IC₅₀s of 27 and 25 nM, respectively.

相關檔案下載

相關產品